[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-362608-105":59,"doc-detail-362608-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","multimodal-management-of-primary-mixed-neuroendocrine-prostate-cancer-with-bone-flare-phenomenon-a-rare-case-report-and-therapeutic-insights","Multimodal management of primary mixed neuroendocrine prostate cancer with bone flare phenomenon - a rare case report and therapeutic insights","","Neuroendocrine prostate cancer (NEPC) is a rare, aggressive prostate malignancy, and mixed NEPC combines adenocarcinoma and neuroendocrine components with limited clinical experience. A 77-year-old man presented with scrotal swelling, urinary symptoms, and leg edema, with imaging showing locally advanced disease and metastases. Biopsy confirmed mixed NEPC, treated with ADT, an ARPI, docetaxel, and pelvic radiotherapy. Follow-up showed radiographic regression but new bone lesions interpreted as bone flare, with stable clinical status and PSA \u003C0.1 ng/mL at seven months.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/multimodal-management-of-primary-mixed-neuroendocrine-prostate-cancer-with-bone-flare-phenomenon-a-rare-case-report-and-therapeutic-insights/362608/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/multimodal-management-of-primary-mixed-neuroendocrine-prostate-cancer-with-bone-flare-phenomenon-a-rare-case-report-and-therapeutic-insights/362608.png","ImageObject",300,407,{"name":92,"@type":93},"Riley West","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical features and imaging findings were reported in this case?","Question",{"text":112,"@type":113},"A 77-year-old man presented with scrotal swelling, lower urinary tract symptoms, and bilateral leg edema. Imaging showed locally advanced prostate cancer with lymph node and bone metastases.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was mixed neuroendocrine prostate cancer confirmed?",{"text":117,"@type":113},"Prostate biopsy demonstrated mixed neuroendocrine prostate cancer, including neuroendocrine carcinoma and acinar adenocarcinoma (Gleason score 4+5=9). Immunohistochemical findings showed absence of RB, PTEN, and p53 protein expression.",{"name":119,"@type":110,"acceptedAnswer":120},"How were new bone lesions during treatment interpreted?",{"text":121,"@type":113},"New bone lesions detected two months into follow-up were interpreted as a bone flare phenomenon within the overall clinical context. Subsequent follow-up showed clinical stability without radiographic progression and PSA levels below 0.1 ng/mL at seven months.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},362608,1790477256,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":29,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},1099523885074,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Xu and Wang BMC Urology (2026) 26:61 [https://doi.org/10.1186/s12894-026-02064-x](https://doi.org/10.1186/s12894-026-02064-x)  \nBMC Urology  \nCASE REPORT Open Access  \nMultimodal management of primary mixed neuroendocrine prostate cancer with bone flare phenomenon: a rare case report and therapeutic insights  \nLijing Xu1*† and Jialin Wang1†  \nAbstract  \nBackground Neuroendocrine prostate cancer (NEPC) is a rare and aggressive subtype of prostate cancer, accounting for approximately 0. 5%–2% of cases. Mixed NEPC, composed of both adenocarcinoma and neuroendocrine components, represents a biologically heterogeneous entity with limited clinical experience.  \nCase presentation A 77-year-old man presented with scrotal swelling, lower urinary tract symptoms, and bilateral leg edema. Imaging demonstrated locally advanced prostate cancer with lymph node and bone metastases.  \nProstate biopsy revealed mixed neuroendocrine prostate cancer, consisting of neuroendocrine carcinoma andacinar adenocarcinoma (Gleason score 4 + 5=9) . Immunohistochemical staining showed absence of RB, PTEN, and p53 protein expression; molecular genetic testing was not performed. The patient was treated with a multimodal regimen including androgen deprivation therapy (ADT), an androgen receptor pathway inhibitor (ARPI), docetaxel chemotherapy, and pelvic radiotherapy. During follow-up, radiographic regression of metastatic lesions and  \nclinical improvement were observed. New bone lesions detected at two months were interpreted as a bone flare phenomenon in the overall clinical context. At seven months of follow-up, the patient remained clinically stable, with PSA levels below 0.1 ng/mL and no evidence of radiographic progression.  \nConclusion This report describes the clinical course of a patient with mixed neuroendocrine prostate cancer managed with multimodal therapy and highlights the interpretive challenges associated with imaging changes, including the bone flare phenomenon, during treatment. Given the inherent limitations of a single case, no conclusions regarding treatment efficacy can be drawn. This case underscores the importance of cautious interpretation of PSA kinetics and imaging findings, as well as individualized, multidisciplinary management in this rare and aggressive disease.  \n†Lijing Xu and Jialin Wang contributed equally to this work and were co-first authors.  \n*Correspondence: Lijing Xu [597137071@qq.com](597137071@qq.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nXu and Wang BMC Urology (2026) 26:61 Page 2 of 6  \nKeywords Mixed neuroendocrine prostate cancer, Multimodal therapy, Bone flare phenomenon, Androgen receptor pathway inhibitor, Docetaxel chemotherapy, Pelvic radiotherapy  \nIntroduction  \nNeuroendocrine prostate cancer (NEPC) is a highly aggressive subtype of prostate mal","cbCaicnJY1hhn13o","https://ap.wps.com/l/cbCaicnJY1hhn13o","pdf",1318083,"English","# Abstract\n## Background\n## Case presentation\n## Conclusion\n# Introduction\n# Case report\n## Presentation and diagnostic workup\n## Biopsy and immunohistochemistry","[{\"question\":\"What clinical features and imaging findings were reported in this case?\",\"answer\":\"A 77-year-old man presented with scrotal swelling, lower urinary tract symptoms, and bilateral leg edema. Imaging showed locally advanced prostate cancer with lymph node and bone metastases.\"},{\"question\":\"How was mixed neuroendocrine prostate cancer confirmed?\",\"answer\":\"Prostate biopsy demonstrated mixed neuroendocrine prostate cancer, including neuroendocrine carcinoma and acinar adenocarcinoma (Gleason score 4+5=9). Immunohistochemical findings showed absence of RB, PTEN, and p53 protein expression.\"},{\"question\":\"How were new bone lesions during treatment interpreted?\",\"answer\":\"New bone lesions detected two months into follow-up were interpreted as a bone flare phenomenon within the overall clinical context. Subsequent follow-up showed clinical stability without radiographic progression and PSA levels below 0.1 ng/mL at seven months.\"}]","Multimodal management of primary mixed neuroendocrine prostate cancer with bone flare phenomenon - a rare case report and therapeutic insights | PDF",1790148535,15,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0beeb5abdd4bc7c445c792ad0abea46d.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1ae7d9f77673dc7b5429c1dfdf1d0814.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a9df757bf0c39408b3c4e93cbeadcf7d.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/935e05d83ed42c1e82f45156ae2f6bc7.webp",980,1306]